Filing Details
- Accession Number:
- 0000950170-24-088589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-31 16:14:51
- Reporting Period:
- 2024-07-30
- Accepted Time:
- 2024-07-31 16:14:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1503802 | Karyopharm Therapeutics Inc. | KPTI | Pharmaceutical Preparations (2834) | 263931704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1942597 | Stuart Poulton | C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459 | Evp, Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-07-30 | 2,883 | $1.06 | 326,628 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
